Company remains on track to submit Investigational Device Exemption (“IDE”), and if approved, commence U.S. clinical trials in 2026 to support a De Novo FDA application THE WOODLANDS, TX, Sept. 29, ...
The "GLP Laboratory Compliance Documentation and Recordkeeping" training has been added to ResearchAndMarkets.com's offering.
The United States Food and Drug Administration (USFDA) has issued a Warning Letter to Palamur Biosciences Private Limited, a preclinical contract research laboratory located ...
BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform, today announced that its unified platform for research and clinical informatics has been validated to comply ...
The USFDA issued a warning to Telangana’s Palamur Biosciences for serious Good Laboratory Practice violations, citing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results